Primary HIV-1 Infection Sets the Stage for Important B Lymphocyte Dysfunctions
Kehmia Titanji(Immunocore (United Kingdom)), Angelo De Milito(Sprint Bioscience (Sweden)), Alberto Cagigi(National Institutes of Health), Sven Grützmeier, Francesca Chiodi(Institute of Virology of the Slovak Academy of Sciences), Chiara Tassandin, Danika Schepis, Giuseppe Tambussi(San Raffaele University of Rome), Lucia Lopalco(Vita-Salute San Raffaele University), Lyda M. Osorio, Rino Bellocco(Karolinska Institutet)
Cited by 61
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244